Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C

The results of antiviral therapy for hepatitis C virus (HCV) have improved recently with the use of pegylated interferon (PEG-IFN)/ribavirin (RBV) combination therapy. At this point, most patients with chronic HCV remain untreated. Thus, it is anticipated that therapy will be more appealing and pres...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Nudo, CG, Wong, P, Hilzenrat, N, Deschênes, M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Pulsus Group Inc 2006
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2659944/
https://ncbi.nlm.nih.gov/pubmed/17001400
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller